Day: April 7, 2020

Yhtiömme BBS-Bioactive Bone Substitutes Oyj:n patenttihakemuksen ”A METHOD FOR PREPARING A BONE PROTEIN PREPARATION AND A BONE PROTEIN PREPARATION” tuotevaatimukset on hyväksytty USA:ssa. Nyt yhtiön ARTEBONE®-tuotteelle on myönnetty patentti kaikissa maissa, joissa sitä on haettu. USA:n osalta on vielä menossa tuotteen valmistusta koskeva patenttihakemus. Lisätietoja:Ilkka Kangasniemi, toimitusjohtaja, puh. +35840 7080 307, s-posti: ilkka.kangasniemi@bbs-artebone.fiHyväksytty neuvonantaja: Stockholm Certified Advisers AB, puh. +46 70 5516 729, info@certifiedadviser.seJAKELU:Nasdaq Helsinki OyNasdaq Stockholm ABKeskeiset tiedotusvälineetwww.bbs-artebone.fiTämä on tieto, jonka BBS-Bioactive Bone Substitutes Oyj on velvollinen julkistamaan EU:n markkinoiden väärinkäytön asetuksen mukaisesti. Tiedot on toimitettu julkaisemista varten edellä...

In 2020 Q1, 4.8 million tonnes of cargo and 1.6 million passengers passed through the harbours of Tallinna Sadam. Compared to the same period of previous year, the cargo volume increased 2.0%. The number of passengers in Q1 decreased by 13.3%. The number of ship calls declined by 2.9% to 1585 calls.In terms of passenger numbers, the results of Q1 were mostly affected by the COVID-19 pandemic that broke out in March and the related special measures established in Estonia and neighboring countries, as well as restrictions on passenger transport. The Tallinn-Stockholm route was temporarily closed as of 15 March, and passenger traffic on the Tallinn-Helsinki route decreased significantly in the second half of March due to the closure of the Estonian and Finnish borders for passengers. Operators have also reduced the number of ships sailing...

F-Secure Corporation, Stock Exchange Release, 7 April 2020, at 16.00 EESTF-Secure Corporation – Managers’ Transactions – Jari StillF-Secure Oyj – Managers’ Transactions____________________________________________Person subject to the notification requirementName: Still, JariPosition: Other senior managerIssuer: F-Secure OyjLEI: 743700ATXLT0MFCHXT16Notification type: INITIAL NOTIFICATIONReference number: 743700ATXLT0MFCHXT16_20200407120702_3____________________________________________Transaction date: 2020-04-06Venue not applicableInstrument type: SHAREISIN: FI0009801310Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATIONTransaction details(1): Volume: 660 Unit price: EURAggregated transactions(1): Volume: 660 Volume weighted average price: EUR Contact information:Henri Kiili,  Investor Relations...

F-Secure Oyj, Pörssitiedote, 7.4.2020 klo 16:00F-Secure Oyj – Johdon liiketoimet – Jari StillF-Secure Oyj – Johdon liiketoimet____________________________________________IlmoitusvelvollinenNimi: Still, JariAsema: Muu ylin johtoLiikkeeseenlaskija: F-Secure OyjLEI: 743700ATXLT0MFCHXT16Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 743700ATXLT0MFCHXT16_20200407120702_3____________________________________________Liiketoimen päivämäärä: 2020-04-06Kauppapaikka ei sovelluInstrumenttityyppi: OSAKEISIN: FI0009801310Liiketoimen luonne: OSAKEPALKKION VASTAANOTTAMINENLiiketoimien yksityiskohtaiset tiedot(1): Volyymi: 660 Yksikköhinta: EURLiiketoimien yhdistetyt tiedot(1): Volyymi: 660 Keskihinta: EURLisätietoja:Henri Kiili,  Johtaja – Sijoittajasuhteet ja Treasury, F-Secure Oyj +358 40 840 5450investor-relations@f-secure.com

TORONTO, April 07, 2020 (GLOBE NEWSWIRE) — QuestCap Inc. (“QuestCap” or the “Company”) (CSE: QSC; FRA: 34C1) announced today that it has entered into a profit sharing agreement with More Than Just Rice, Inc. (“MTJR”), subject to the satisfaction of conditions with a Korean diagnostic testing company, for MTJR to exclusively distribute, market and sell COVID19 Antibody Tests in North and South America.  The test will be marketed/distributed in the United States pursuant to the U.S. Food and Drug Administration (FDA)’s policy on COVID-19 serological tests during the public health emergency period.COVID-19 Antibody Test Disclaimers:This test has not been reviewed by the FDA.Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic...

Lyon, Frankreich, April 07, 2020 (GLOBE NEWSWIRE) — Artikel 223-16 der allgemeinen Verordnung der französischen Autorité des Marchés FinanciersLyon – FrankreichBörsennotierung:Euronext Paris von Euronext (Marktsegment C – ISIN-Code: FR0011471135 – Symbol: ERYP) &Nasdaq Global Select Market in den USA (Symbol: ERYP)Website: www.erytech.com        1Die Anzahl der Bruttostimmrechte (bzw. „theoretischen“ Stimmrechte) dient als Grundlage für die Berechnung des Schwellenwerts. Gemäß Artikel 223-11 der allgemeinen Verordnung der Autorité des Marchés Financiers wird diese Zahl auf Basis aller Anteile berechnet, die einfache und doppelte Stimmrechte umfassen, einschließlich Aktien ohne Stimmrechte.2Ohne eigene Aktien.

Lione, Francia, April 07, 2020 (GLOBE NEWSWIRE) —Articolo 223-16 del regolamento generale dell’Autorité des Marchés Financiers franceseLione – FranciaMercati di quotazione:Euronext Paris di Euronext (segmento di mercato C –  codice ISIN: FR0011471135 – simbolo: ERYP) eNasdaq Global Select Market negli Stati Uniti (Simbolo: ERYP)Sito web: www.erytech.com        (1)   Il numero dei diritti di voto lordi (o diritti di voto “teorici”) è utilizzato come base per il calcolo del superamento della soglia. Ai sensi dell’articolo 223-11 del regolamento generale dell’Autorité des Marchés Financiers, questo numero è calcolato sulla base di tutte le azioni con diritto di voto unico e doppio, ivi comprese le azioni senza diritto di voto.(2)   Escluse le azioni proprie.

ATLANTA, April 07, 2020 (GLOBE NEWSWIRE) —UPS managing and brokering 25 flights over the next two weeksUPS-managed Project Airbridge flights delivering more than three million pounds of materials including masks, surgical gowns, gloves, medical swabs and thermometers in high-demand within the U.S. healthcare systemShipments originating from China, Malaysia, Honduras, among other countriesUPS opening new 450,000 square-foot UPS Healthcare facility in Louisville with dedicated space for FEMA UPS managing 24/7 operation of receipt and distribution of PPE, at FEMA’s directionUPS (NYSE:UPS) today announced the company is managing and brokering 25 charter flights in support of Project Airbridge, a coordinated effort between the Federal Emergency Management Agency (FEMA), numerous countries and the private sector designed to expedite the...

HAUPPAUGE, N.Y., April 07, 2020 (GLOBE NEWSWIRE) — Orbit International Corp. (OTC PINK:ORBT), an electronics manufacturer and software solution provider, today announced that consolidated bookings for the first quarter of 2020 exceeded $6,900,000. In addition, the Company also reported that bookings for its Power Group (“OPG”) exceeded $1,200,000 for the month of March 2020.       First quarter bookings were highlighted by a previously announced order by our Orbit Electronics Group (“OEG”) of approximately $2,300,000 for keyboards used on a major military aviation program.   Other orders received during the quarter for the OEG consisted primarily of displays and control panels.  In addition, our OPG reported bookings for the month of March 2020 in excess of $1,200,000, which consisted of a more than $400,000 order for VPX power...

EAST RUTHERFORD, N.J., April 07, 2020 (GLOBE NEWSWIRE) — Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced it has completed an expansion of its biopharmaceutical analysis capabilities at the Durham, North Carolina site. Biopharmaceutical analysis services were initially launched at Durham in 2018 and have since been expanded through the purchase and implementation of various method development, validation, release and stability or endotoxin testing functions.Following this expansion the Durham site now features a range of new instruments, including particle analysis, imaging, qPCR, fluorescent/absorbance plate reader, immunoblotting, mass spectrometry and other compendial testing apparatus. The new capabilities are applicable...